Un programa de ejercicio de 20 semanas mejora marcadores de estatus cognitivo, inflamatorios y metabólicos en pacientes diabéticos tipo 2
Abstract
Diabetes mellitus type 2 is a disorder caused by insulin resistance in 90 per cent of cases and determines risk of vascular dementia and Alzheimer’s disease. Low grade chronic and systemic inflammation determines a loss in insulin sensitivity in the brain and cognitive deterioration.
The study aimed to assess the impact of a 20 week exercise program on the cognitive (including quality of life) and inflammatory status in a sample of patients with type 2 diabetes mellitus whose diagnosis is ten years or less, assisted in our national integrated health system.
Method: clinical, open, randomised and controlled study on patients of the primary level of care. 41 out of 168 patients with type 2 diabetes mellitus recruited met the inclusion criteria. The sample was divided into two homogeneous groups. Both groups underwent cognitive tests and blood samples were taken to measure inflammatory and metabolic markers, before and after the exercise program.
Results: cognitive and quality of life improvement were correlated to a significant decrease of inflammation markers: IL-6 and ferritin, as well as of metabolic markers. Unlike this, no improvement was seen in the control group.
Conclusions: early and regular application of the 20 week controlled exercise program or similar to treat patients with type 2 diabetes mellitus who are followed by our national integrated health system may contribute to preventing cognitive deterioration and Alzheimer’s disease.
References
(1) International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels: International Diabetes Federation, 2013.
(2) Alzheimer's Association. 2013 Alzheimer's disease facts and figures. Alzheimers Dement 2013; 9(2):208-45.
(3) Asociación Uruguaya de Alzheimer y Similares. Montevideo: AUDAS, 2018. Disponible en: http://www.audas.org.uy/. Consulta: 19 abril 2018.
(4) Ott A, Stolk R, Hofman A, van Harskamp F, Grobbee D, Breteler M. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39(11):1392-7,
(5) Han W, Li C. Linking type 2 diabetes and Alzheimer's disease. Proc Natl Acad Sci U S A 2010; 107(15):6557-8.
(6) Marioni R, Strachan M, Reynolds R, Lowe G, Mitchell R, Fowkes F, et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010; 59(3):710-3.
(8) Freeman D, Norrie J, Caslake M, Gaw A, Ford I, Lowe G, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002; 51(5):1596-600.
(9) Perry V. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 2004; 18(5):407-13.
(10) Bosco D, Fava A, Plastino M, Montalcini T, Pujia A. Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis. J Cell Mol Med 2011; 15(9):1807-21.
(11) Talbot K, Wang HY, Kazi H, Han L, Bakshi K, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012; 122(4):1316-38.
(12) Hotamisligil G. Inflammation and metabolic disorders. Nature 2006; 444(7121):860-7.
(13) Lumeng C, Saltiel A. Inflammatory between obesity and metabolic disease. J Clin Invest 2011; 121(6):2111-7.
(14) Hillman C, Belopolsky A, Snook E, Kramer A, McAuley E. Physical activity and executive control: implications for increased cognitive health during older adulthood. Res Q Exerc Sport 2004; 75(2):176-85.
(15) Colcombe S, Erickson K, Raz N, Webb A, Cohen N, McAuley E, et al. Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol A Biol Sci Med Sci 2003; 58(2):176-80.
(16) van Praag H. Neurogenesis and exercise: past and future directions. Neuromolecular Med 2008; 10(2):128-40.
(17) Erickson K, Voss M, Prakash R, Basak C, Szabo A, Chaddock L, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A 2011; 108(7):3017-22.
(18) Zisser H, Gong P, Kelley C, Seidman J, Riddell M. Exercise and diabetes. Int J Clin Pract Suppl 2011; (170):71-5.
(19) Angevaren M, Aufdemkampe G, Verhaar H, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2008; (3):CD005381.
(20) Cotman C, Berchtold N, Christie L. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007; 30(9):464-72.
(21) Pedersen BK. Muscles and their myokines. J Exp Biol 2011; 214(Pt 2):337-46.
(22) Lista I, Sorrentino G. Biological mechanisms of physical activity in preventing cognitive decline. Cell Mol Neurobiol 2010; 30(4):493-503.
(23) Martínez-Lapiscina E, Clavero P, Toledo E, Estruch R, Salas-Salvadó J, San Julián B, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry 2013; 84(12):1318-25.
(24) Esposito K, Giugliano D. Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J 2006; 27(1):15-20.
(25) Eskelinen M, Ngandu T, Helkala E, Tuomilehto J, Nissinen A, Soininen H, et al. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int J Geriatr Psychiatry 2008; 23(7):741-7.
(26) Nooyens A, Baan C, Spijkerman A, Verschuren W. Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study. Diabetes Care 2010; 33(9):1964-9.
(27) Consort Transparent Reporting of Trials. CONSORT 2010 flow diagram. Oxford, UK: CONSORT Group, 2010, Disponible en: http://www.consort-statement.org/consort-2010. Consulta: 1/5/18.
(28) Schneider S. The International Standard Classification of Education 2011. En: Birkelund GE, ed. Class and stratification analysis (Comparative social research; 30) Bingley: Emerald Group, 2013:365-79.
(29) Uruguay. Instituto Nacional de Estadística. VII Censo General de Población, III de Hogares y V de Viviendas 1996. Montevideo: INE, 1996. Disponible en: http://www. ine.gub.uy/web/guest/censo-1996. Consulta:20/3/18.
(30) Pate R, Pratt M, Blair S, Haskell W, Macera C, Bouchard C, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273(5):402-7.
(31) Martínez de la Iglesia J, Onís Vilches M, Dueñas Herrero R, Albert Colomer C, Aguado Taberné C, Luque Luque R. Versión española del cuestionario de Yesavage abreviado (GDS) para el despistaje de depresión en mayores de 65 años: adaptación y validación. Medifam 2002; 12(10):620-30.
(32) Lucas-Carrasco R. The WHO quality of life (WHOQOL) questionnaire: Spanish development and validation studies. Qual Life Res 2012; 21(1):161-5.
(33) Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges J. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21(11):1078-85.
(34) Kline G, Porcari J, Hintermeister R, Freedson P, Ward A, McCarron R, et al. Estimation of VO2max from a one-mile track walk, gender, age, and body weight. Med Sci Sports Exerc 1987; 19(3):253-9.
(35) American Diabetes Association. Standards of medical care in Diabetes: 2015 abridged for primary care providers. Clin Diabetes 2015; 33(2):97-111.
(36) Suzuki S, Tanaka K, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 2009; 29(3):464-79.
(37) Forouhi N, Harding A, Allison M, Sandhu M, Welch A, Luben R, Bingham S, et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007; 50(5):949-56.
(38) Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics 2014; 6(4):748-73.
